Alterity Therapeutics
ATHE
13 hedge funds and large institutions have $952K invested in Alterity Therapeutics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
2% less capital invested
Capital invested by funds: $975K → $952K (-$23K)
7% less funds holding
Funds holding: 14 → 13 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$13.2K |
| 3 |
NFG
Next Financial Group
Houston,
Texas
|
+$1.21K |
| 4 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
+$541 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$71.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$22K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.58K |
| 4 |
Renaissance Technologies
New York
|
-$4.58K |
| 5 |
LC
Landaas & Company
Milwaukee,
Wisconsin
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $421K | +$24.8K | +1,191 | +6% |
|
|
CWM
2
Cornerstone Wealth Management
St. Peters,
Missouri
| $333K | +$541 | +26 | +41% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $70K | -$71.3K | -3,425 | -50% |
|
|
4
Renaissance Technologies
New York
| $51K | -$4.58K | -220 | -8% |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $49K | -$4.58K | -220 | -8% |
|
|
6
UBS Group
Zurich,
Switzerland
| $16K | +$13.2K | +636 | +464% |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $5K | – | – | – |
|
|
OIA
8
Optimum Investment Advisors
Chicago,
Illinois
| $3K | – | – | – |
|
|
AIM
9
Advantage Investment Management
Cedar Rapids,
Iowa
| $2K | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
NFG
11
Next Financial Group
Houston,
Texas
| $1K | +$1.21K | +58 | New |
|
|
APA
12
American Portfolios Advisors
Holbrook,
New York
| $167 | – | – | – |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$22K | -1,172 | Closed |
|
|
LC
14
Landaas & Company
Milwaukee,
Wisconsin
| – | -$1K | -67 | Closed |
|
ATHE Hedge Fund Activity: Q3 2018 in Review
13 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2018, worth a combined $952K — down 2.4% from $975K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ATHE and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.
The largest buyer was Morgan Stanley, adding an estimated $24.8K. The largest seller was Susquehanna International Group, cutting an estimated $71.3K.
- 13 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2018, down from 14 in Q2 2018.
- Funds reported $952K of Alterity Therapeutics stock for Q3 2018, down 2.4% quarter-over-quarter.
- 1 fund opened new Alterity Therapeutics positions in Q3 2018 and 2 closed out, a net change of -1 holder.
- The largest Alterity Therapeutics buyer in Q3 2018 was Morgan Stanley, an estimated $24.8K added.
- The largest Alterity Therapeutics seller in Q3 2018 was Susquehanna International Group, an estimated $71.3K sold.
Based on aggregated 13F filings for Q3 2018.